Cellectar Biosciences
CLRB
6 hedge funds and large institutions have $7.52M invested in Cellectar Biosciences in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
9% less capital invested
Capital invested by funds: $8.3M → $7.52M (-$779K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$1.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$262K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
1
AWM Investment Company
New York
| $4.12M | – | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $1.64M | -$262K | -3 | -14% |
|
|
CAM
3
Cormorant Asset Management
Boston,
Massachusetts
| $1.53M | – | – | – |
|
|
BA
4
Bard Associates
Chicago,
Illinois
| $124K | – | – | – |
|
5
Goldman Sachs
New York
| $79K | – | – | – |
|
6
Morgan Stanley
New York
| $10K | – | – | – |
|
|
BCM
7
Brookstone Capital Management
Wheaton,
Illinois
| $6K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $4K | – | – | – |
|
9
Bank of America
Charlotte,
North Carolina
| $3K | – | – | – |
|
|
SSB
10
Sandy Spring Bank
Olney,
Maryland
| $2K | – | – | – |
|
|
AIG
11
American International Group
New York
| $14 | – | – | – |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | -$3K | – | – |
|
|
PRCM
13
Pine River Capital Management
Minnetonka,
Minnesota
| – | +$1.49M | +17 | New |
|
CLRB Hedge Fund Activity: Q2 2015 in Review
6 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences (CLRB) for Q2 2015, worth a combined $7.52M — down 9.4% from $8.3M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CLRB positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Pine River Capital Management, opening a new position worth an estimated $1.49M. The largest seller was Sabby Management, cutting an estimated $262K.
- 6 institutional investors held Cellectar Biosciences (CLRB) as of Q2 2015, up from 5 in Q1 2015.
- Funds reported $7.52M of Cellectar Biosciences stock for Q2 2015, down 9.4% quarter-over-quarter.
- 1 fund opened new Cellectar Biosciences positions in Q2 2015 and 0 closed out, a net change of +1 holder.
- The largest Cellectar Biosciences buyer in Q2 2015 was Pine River Capital Management, an estimated $1.49M added.
- The largest Cellectar Biosciences seller in Q2 2015 was Sabby Management, an estimated $262K sold.
Based on aggregated 13F filings for Q2 2015.